The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
In this Axios column, Drew Altman says full FDA approval of COVID-19 vaccines can provide a big boost to vaccination efforts if treated as an opportunity for updated messaging from government officials at all levels and public health experts and new actions from employers.
August 25, 2021 – THE CONVERSATION / LA CONVERSACIÓN expands to address questions about the COVID-19 vaccines and children with new FAQ videos featuring pediatricians. This installment of the campaign is produced by KFF (Kaiser Family Foundation) under its Greater Than COVID public information response and is presented with the American Academy of Pediatrics (AAP). Vaccine safety, efficacy and potential side effects, as well as the need for vaccinations among children, are among issues highlighted…
This new analysis examines the experiences of LGBT adults from the July COVID-19 Vaccine Monitor and finds that as a group they are more likely to be vaccinated for COVID-19 and less likely to view getting the vaccine as a health risk compared to non-LGBT adults. A larger share of LGBT adults than non-LGBT adults say they have received at least one dose of a COVID-19 vaccine (82% vs 66%) and are more supportive of…
The Latest KFF COVID-19 Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. Black and Hispanic adults remain more likely to want to wait and see how the vaccine is working for others before getting it themselves.
In this Axios column, Drew Altman paints a more optimistic picture of the prospects for getting to herd immunity as vaccine confidence grows, but underscores the urgency of building vaccine confidence in Black and Latino communities where barriers to access and good information are obstacles to getting vaccinated.
While the toll of COVID-19 on nursing home residents has been well documented, less noticed has been the experience of nonelderly people with disabilities who rely on long-term care services and supports outside of nursing homes. In many ways the two groups face similar health risks from the virus, but nonelderly people with disabilities generally do not have the same high priority status for the vaccine, finds a new KFF analysis. As of early February…
As of Feb. 14, 2021, weekly new deaths among nursing home residents have decreased by 83% since long-term care vaccination efforts started at the end of December, compared to a 67% increase in new deaths among all non-nursing home residents during the same period. Learn more in this Chart of the Week.
This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.
This month the Centers for Disease Control and Prevention (CDC) adopted a recommendation that health care workers and long-term care residents should be the first to receive the COVID-19 vaccine once it is authorized or approved by the FDA. A new KFF analysis estimates there are 15.5 million people working in health care settings who have direct patient contact, 1.2 million nursing facility residents and another 800,000 assisted living facility residents nationwide. These 17.6 million…
This initial survey for the KFF COVID-19 Vaccine Monitor tracks the public’s attitudes and experiences with COVID-19 vaccinations, with a focus on sub-groups of Americans. It explores confidence in vaccines, assesses trust in messengers, and highlights key challenges for vaccination efforts.
© 2026 KFF
